↓ Cooling
Business
🔮 fades ✓
What to Know About New Covid Vaccines for Fall 2026
5 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
Moderna
15 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Moderna
This hub groups 15 separate news trends connected to Moderna, spanning June 19, 2026 through August 27, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 153 article observations and 135 source signals, led by Business, Health coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 fades ✓
There’s a new type of flu vaccine for older adults this year. Can you get it?
A new mRNA flu vaccine for older adults has been approved, but availability remains uncertain.
↑ Rising
Business
🔮 fades ✓
Moderna, Merck breakthrough could usher in wave of cancer vaccines
A cancer vaccine breakthrough from Moderna and Merck has investors and patients hopeful, but questions remain.
◼ Archived
Business
🔮 fades ✓
Quant hedge funds suffer worst day in 2 years as Treasury boosts buyback and Moderna shares leap
Quant hedge funds suffered their worst day in two years on August 20, 2026.
◼ Archived
Business
🔮 fades ✓
Why Is Moderna Stock Down Today?
Moderna's stock is down despite promising news about a cancer vaccine.
◼ Archived
Business
🔮 fades ✓
After Moderna stock surge of 177% on cancer drug breakthrough, here's what Wall Street thinks happens next
Moderna's stock surge on a cancer drug breakthrough has Wall Street abuzz with speculation about the future of cancer treatment.
◼ Archived
Business
🔮 fades ✓
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
Shares of Moderna have doubled after its cancer vaccine trial with Merck met key endpoints.
◼ Archived
Business
🔮 fades ✓
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Moderna's stock surged 160% after the company and Merck announced success in a late-stage melanoma vaccine trial
◼ Archived
Health
‘Mismatched’ vaccine being rolled out against Ebola outbreak
Public health agencies are deploying an Ebola vaccine that does not perfectly match the circulating virus strain while preparing new clinical trials.
◼ Archived
Business
🔮 holds ✗
F.D.A. Approves Moderna’s mRNA Flu Vaccine
The FDA's approval of Moderna's mRNA flu vaccine marks a significant shift in seasonal flu prevention, particularly for older adults.
◼ Archived
Health
🔮 fades ✓
FDA approves 1st mRNA flu shot, from Moderna
The FDA has approved the first mRNA flu vaccine, marking a significant shift in flu shot technology.
◼ Archived
Health
🔮 fades ✓
Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak
Moderna's Phase 1 Ebola vaccine trial begins as the outbreak in DR Congo continues to spread
◼ Archived
Health
🔮 fades ✓
DR Congo Ebola outbreak kills more than 1,700 as WHO accelerates trials
An Ebola outbreak in the Democratic Republic of Congo has surpassed 1,700 deaths as Moderna initiates clinical trials for a new vaccine candidate.
◼ Archived
Business
🔮 fades ✓
Stock Market Today: S&P 500, Nasdaq Slip; Greenspan Tributes Roll In
Moderna's stock surge and tech sector volatility drive market trends as investors react to geopolitical developments.
◼ Archived
Business
🔮 fades ✓
New First-of-Its-Kind Flu Vaccine Approved by FDA Expert Panel
An FDA advisory panel has unanimously endorsed Moderna's first-of-its-kind mRNA-based seasonal influenza vaccine, mRNA-1010.